- Home
- DNUT vs MGTX Comparison
DNUT vs MGTX Comparison
Compare DNUT & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNUT
- MGTX
- Stock Information
- Founded
- DNUT 1937
- MGTX 2015
- Country
- DNUT United States
- MGTX United States
- Employees
- DNUT N/A
- MGTX N/A
- Industry
- DNUT Food Chains
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DNUT Consumer Staples
- MGTX Health Care
- Exchange
- DNUT Nasdaq
- MGTX Nasdaq
- Market Cap
- DNUT 578.7M
- MGTX 670.2M
- IPO Year
- DNUT 2021
- MGTX N/A
- Fundamental
- Price
- DNUT $3.13
- MGTX $7.33
- Analyst Decision
- DNUT Buy
- MGTX Strong Buy
- Analyst Count
- DNUT 6
- MGTX 2
- Target Price
- DNUT $6.22
- MGTX $24.00
- AVG Volume (30 Days)
- DNUT 3.6M
- MGTX 284.2K
- Earning Date
- DNUT 11-06-2025
- MGTX 11-12-2025
- Dividend Yield
- DNUT 3.37%
- MGTX N/A
- EPS Growth
- DNUT N/A
- MGTX N/A
- EPS
- DNUT N/A
- MGTX N/A
- Revenue
- DNUT $1,538,841,000.00
- MGTX $37,917,000.00
- Revenue This Year
- DNUT N/A
- MGTX $145.67
- Revenue Next Year
- DNUT $2.93
- MGTX $167.61
- P/E Ratio
- DNUT N/A
- MGTX N/A
- Revenue Growth
- DNUT N/A
- MGTX 366.84
- 52 Week Low
- DNUT $2.50
- MGTX $3.94
- 52 Week High
- DNUT $12.68
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- DNUT 40.87
- MGTX 42.71
- Support Level
- DNUT $2.95
- MGTX $7.39
- Resistance Level
- DNUT $3.24
- MGTX $7.91
- Average True Range (ATR)
- DNUT 0.18
- MGTX 0.36
- MACD
- DNUT -0.04
- MGTX -0.00
- Stochastic Oscillator
- DNUT 19.57
- MGTX 19.89
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.